Face transplantation: The view from Paris, France

Southern Medical Journal

Volumn 99, Issue 4, 2006, Pages 421-423

  Lantieri, Laurent A ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; BASAL CELL CARCINOMA; COMPOSITE GRAFT; CONVALESCENCE; CUSHING SYNDROME; CYTOMEGALOVIRUS INFECTION; DETERIORATION; DIABETES MELLITUS; FACE TRANSPLANTATION; FRANCE; HERPES; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; METABOLIC DISORDER; MYCOSIS; MYELOABLATIVE CONDITIONING; OPPORTUNISTIC INFECTION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SAFETY; POSTOPERATIVE PERIOD; RISK BENEFIT ANALYSIS; SHORT SURVEY; SIDE EFFECT; SKIN INFECTION; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TINEA; TRANSPLANTATION;

ESTHETICS; FACIAL INJURIES; FRANCE; GRAFT REJECTION; HAND; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; PATIENT COMPLIANCE; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33646476413     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000210143.28625.21     Document Type: Short Survey

References (2)

1. Andrew Lee WP. Perspectives on hand transplantation. Clinical Plast Surg 2005;32:463-470.
2. National Consultative Ethics Committee for Health and Life Sciences Opinion No 82, Composite tissue allotransplantation (CTA) of the face. Available at: http://www.ccne-ethique.fr/english/start.htm.